摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(2-methyl-4-propyl-piperazin-1-yl)-ethanol | 91015-34-8

中文名称
——
中文别名
——
英文名称
2-(2-methyl-4-propyl-piperazin-1-yl)-ethanol
英文别名
2-(2-Methyl-4-propylpiperazin-1-yl)ethanol
2-(2-methyl-4-propyl-piperazin-1-yl)-ethanol化学式
CAS
91015-34-8
化学式
C10H22N2O
mdl
——
分子量
186.297
InChiKey
HTXSOTOKETYMBP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    13
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    26.7
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • DERIVATIVES OF 2-PHENYL-3-HYDROXYQUINOLINE-4(1H)-ONE AND METHODS OF THEIR PREPARATION AND UTILIZATION
    申请人:Krejci Petr
    公开号:US20100022587A1
    公开(公告)日:2010-01-28
    Derivatives of 2-phenyl-3-hydroxyquinoline-4(1H)-one of the general formula (II), where X represents a nitro group, amino group, and Y represents an atom of halogen, oxygen or sulphur substituted by C 1 to C 6 alkyl or phenyl group, whereby both the alkyl and phenyl group may be further substituted and the substituents may be identical or different, or by nitrogen substituted independently by hydrogen, C 1 to C 6 alkyl, C 1 to C 6 alkyl, which may be substituted among others by halogen, hydroxy, C 1 to C 4 alkoxy or C 1 to C 4 alkylamino group, or may form a saturated or unsaturated heterocyclic ring with 5 to 7 atoms, where the individual ring atoms comprise atoms of carbon, and any of the carbon atoms may be substituted by an atom of nitrogen, sulphur or oxygen, X and Y together form an imidazo group, or imidazo group substituted by C 1 to C 6 alkyl, which may be substituted among others by halogen, hydroxy, C 1 to C 4 alkoxy or C 1 to C 4 alkylamino group, CHO or acetylgroup, or a heterocyclic ring with 5 to 6 atoms, where the ring atoms may be further substituted. Methods of preparation of these compounds are described. In addition, their cytostatic, cytotoxic, antiproliferation and immunosuppressive activity is described including examples of their potential pharmacological and pharmaceutical utilization.
  • US8299092B2
    申请人:——
    公开号:US8299092B2
    公开(公告)日:2012-10-30
查看更多